Quantitative finance continues to debate the reliability and limits of model-driven investment strategies. Read more here.
Investigating the novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager, AFM24, to leverage the innate immune system: Interim results from the colorectal cancer (CRC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results